4 Patents
- US122866772025Inhibition of HSD17B13 in the Treatment of Liver Disease in Patients Expressing the PNPLA3 I148M Variation
Regeneron Pharmaceuticals, Inc.
0 cites - US118459892023Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117675262023Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117027002023Inhibition of HSD17B13 in the Treatment of Liver Disease in Patients Expressing the PNPLA3 I148M Variation
Regeneron Pharmaceuticals, Inc.
0 cites